Taken together, we clearly demonstrated that plasma levels of ZFAS1 are higher in HCC patients than that in healthy controls and in patients with cirrhosis and hepatitis B, and the expression of ZFAS1 is correlated to serum AFP. This evidence concerns the gene AFP and hepatocellular carcinoma.